30/03/2022 - 16:32

Memphasys notches up more sales of its IVF technology

30/03/2022 - 16:32


Upgrade your subscription to use this feature.

Memphasys Limited has sold more units of its sperm separation system known as “Felix” to two of its current customers, Diagens Biotechnology Company in China and the Indian Women’s Centre IVF clinic in Coimbatore, India. According to the company, receiving repeat orders from patrons within its existing consumer base validates its business model and confirms its products efficiency across both research and clinical platforms.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options